Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
作者信息
Ichimaru K, Toyoshima S, Uyama Y
机构信息
Office of New Drugs III, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
出版信息
Clin Pharmacol Ther. 2010 Mar;87(3):362-6. doi: 10.1038/clpt.2009.285. Epub 2010 Jan 27.
PMID:20107436
Abstract
摘要
Zotero 插件